PGA Tour: Baycurrent Classic Second Round Leader
Markets
Every market on this event, moneyline first. Select one to compare it across platforms in the side panel.
| Outcome | Best | Volume | Azuro | Gemini | Kalshi | Limitless | Novig | Polymarket | Polymarket US |
|---|---|---|---|---|---|---|---|---|---|
Keith Mitchell Favorite | 53.9%Polymarket US | — | — | — | — | — | — | No liquidity50.0% | |
Jacob Bridgeman | 19.1%Polymarket US | — | — | — | — | — | — | No liquidity50.0% | |
Michael Brennan | 8.6%Polymarket US | — | — | — | — | — | — | No liquidity50.0% | |
Zach Bauchou | 3.4%Polymarket US | — | — | — | — | — | — | No liquidity50.0% | |
Collin Morikawa | 1.9%Polymarket US | — | — | — | — | — | — | No liquidity50.0% | |
Description from Polymarket. A cross-platform summary is generated once this event is matched across platforms.
This market will resolve according to the player that finishes Round 2 of the main tournament at the 2026 Baycurrent Classic with the lowest cumulative score to par. In the event of a tie, this market will resolve in favor of the player with the lower score in Round 2. If a tie still persists, this market will resolve in favor of the player with the lower score in Round 1. If a tie still persists, this market will resolve in favor of the player that records more eagles thus far in the main tournament. If a tie still persists, this market will resolve in favor of the player who records more birdies thus far in the main tournament. If a tie still persists, this market will resolve in favor of the player who records fewer bogeys thus far in the main tournament. If a tie still persists, this market will resolve in favor of the player whose listed last name comes first alphabetically. If the 2026 Baycurrent Classic is cancelled, postponed after October 24, 2026, 11:59 PM ET, or if an official Round 2 leader has not been declared within that timeframe, this market will resolve to "Other". The primary resolution source will be the official results published by the event organizer or governing body.
Discussion (0)
Log in to join the discussion.
No comments yet — start the discussion.